Moderna’s Combo COVID-19 And Flu mRNA Shot Outperforms Current Vaccines, Study Shows

The AP (5/7, Johnson) reports researchers from Moderna said in a study published Wednesday in JAMA that a combination shot for flu and COVID-19 using messenger RNA “generated a stronger immune response against COVID-19 and most strains of flu than existing standalone shots in people 50 and older.” The mRNA technology is already “used in approved COVID-19 and RSV shots, but has not yet been approved for a flu shot.”